Tyme Technologies to Participate at the Oppenheimer Oncology Insight Summit on May 16th

NEXT STORY
Crown Bioscience Announces San Diego, CA Site Expansion
PREV STORY
Progenics Pharmaceuticals Announces First Quarter 2019 Financial Results and Business Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Valeo Pharma Announces $10.0 Million Bought-Deal Public Offering of Units

author_avatar
NASDAQ Market News

Basilea reports derazantinib/PD-L1 checkpoint inhibitor combination results from dose-finding part of FIDES-02 study in patients with solid tumors at ASCO GU symposium

author_avatar
NASDAQ Market News

SEngine Precision Medicine’s PARIS® Test to Guide Personalized Treatment Demonstrates Clinical Utility in Metastatic Colorectal Cancer Study Published in AACR’s Clinical Cancer Research

author_avatar
NASDAQ Market News